Alpha Teknova Valuation Multiples

Alpha Teknova Overview

About Alpha Teknova

Alpha Teknova Inc provides critical reagents that enable the discovery, development, and production of biopharmaceutical products such as drug therapies, novel vaccines, and molecular diagnostics. Its offer three product types: pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification. It derives key revenue from United States.

Founded

2000

HQ

Employees

173

Website

teknova.com

Sectors

Life Sciences ToolsBioTechLongevity

Financials (LTM)

Revenue: $41M

EBITDA: ($7M)

EV

$132M

Valuation Multiples

Multiples.vc

Start free trial

Alpha Teknova Financials

Alpha Teknova reported last 12-month revenue of $41M and negative EBITDA of ($7M).

In the same LTM period, Alpha Teknova generated $14M in gross profit, ($7M) in EBITDA losses, and had net loss of ($17M).

Alpha Teknova P&L

In the most recent fiscal year, Alpha Teknova reported revenue of $41M and EBITDA of ($7M).

Alpha Teknova expects next 12-month revenue of XXX and NTM EBITDA of XXX

Alpha Teknova Stock Performance

Alpha Teknova has current market cap of $125M, and enterprise value of $132M.

Alpha Teknova's stock price is $2.34.

Alpha Teknova Valuation Multiples

Alpha Teknova trades at 3.2x EV/Revenue multiple, and (19.6x) EV/EBITDA.

Alpha Teknova Financial Valuation Multiples

As of March 21, 2026, Alpha Teknova has market cap of $125M and EV of $132M.

Equity research analysts estimate Alpha Teknova's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

Alpha Teknova has a P/E ratio of (7.2x).

Alpha Teknova Margins & Growth Rates

Alpha Teknova's revenue in the last 12 month grew by 8%.

Alpha Teknova's revenue per employee in the last FY averaged $0.2M.

Alpha Teknova's rule of 40 is (9%) (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Alpha Teknova's rule of X is 3% (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

Alpha Teknova Public Comps

See public comps and valuation multiples for other Life Sciences Tools comps.

Alpha Teknova M&A Activity

Alpha Teknova acquired XXX companies to date.

Last acquisition by Alpha Teknova was on XXXXXXXX, XXXXX. Alpha Teknova acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).

Alpha Teknova Investment Activity

Alpha Teknova invested in XXX companies to date.

Alpha Teknova made its latest investment on XXXXXXXX, XXXXX. Alpha Teknova invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).